NCT05608421

Brief Summary

This study tests a 5-session cognitive behavioral approach program (herein referred to as the 1MoreStep intervention) to train Black women living with HIV (BWLWHI) and exposed to intimate partner violence (IPV) in the past 2 years (hereafter, BWLWHI) in: 1) cognitive and behavioral skills to access internal and external sources of strength (e.g. self-reliance, safety net); safety strategies, knowledge about Undetectable = Untransmissible (U=U) and HIV care; and reduce internalized and anticipated stigma; 2) communication skills to respond to enacted HIV and IPV stigma and enlist social support; and 3) addressing structural barriers to HIV care engagement with an HIV navigator component. The intervention is informed by the HIV-Stigma Framework and a resilient-reintegration model which views women as active participants in responding to IPV and managing life with HIV. Aim 1: Examine preliminary efficacy of the 1MoreStep intervention on: (a) IPV safety strategies (informal and formal resources, safety planning, and placating strategies at baseline, 3-month and 6-month follow-up visits); and (b) HIV care engagement (medical record confirmed visit with an HIV care provider, antiretroviral therapy (ART) prescription, medication adherence, and viral load status during 3-month and 6-month follow-up visits). Aim 2: Examine the acceptability and feasibility of the 1MoreStep intervention operationalized by (a) quantitative measures: session attendance and fidelity to key intervention components and (b) qualitative interviews to assess: program fit, facilitators and barriers to participation, and using 1MoreStep intervention skills.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
7mo left

Started Jun 2023

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress83%
Jun 2023Dec 2026

First Submitted

Initial submission to the registry

October 31, 2022

Completed
8 days until next milestone

First Posted

Study publicly available on registry

November 8, 2022

Completed
8 months until next milestone

Study Start

First participant enrolled

June 26, 2023

Completed
3.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2026

Expected
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2026

Last Updated

April 29, 2026

Status Verified

April 1, 2026

Enrollment Period

3.2 years

First QC Date

October 31, 2022

Last Update Submit

April 23, 2026

Conditions

Keywords

HIVIntimate Partner Violence (IPV)Black womenCognitive behavioral approachRandomized Control Trial (RCT)

Outcome Measures

Primary Outcomes (4)

  • Acceptability of study as measured by the Treatment Acceptance Scale

    This scale has scores that range from 8 to 40. Low acceptability scores will be between 8 and 24, and high acceptability scores will be between 17 and 40.

    Week 7

  • Acceptability of study as measured by the Treatment Acceptance Scale

    This scale has scores that range from 8 to 40. Low acceptability scores will be between 8 and 24, and high acceptability scores will be between 17 and 40.

    3 month follow up

  • Acceptability of study as documented in in-depth interviews

    Interviews will assess program fit, facilitators and barriers to participation, and use of 1MoreStep intervention skills.

    3 month follow up

  • Feasibility of study as measured by session attendance

    Session attendance

    Week 7

Secondary Outcomes (5)

  • Change in Intimate Partner Violence safety strategies as measured by the Intimate Partner Violence Safety Strategies Index

    Baseline, Week 7 and 3 month follow up

  • Change in Self-reported HIV Care Engagement in the form of ART medication use

    Baseline, Week 7 and 3 month follow up

  • Change in Use of prescription ART medication as assessed by chart review of HIV Care Engagement

    Baseline, 3 month follow up and 1 year

  • Change in Number of HIV Care Provider visits as assessed by self-reported HIV Care Engagement

    Baseline, Week 7 and 3 month follow up

  • Change in Number of HIV Care Provider visits as assessed by Chart review of HIV Care Engagement

    Baseline, 3 month follow up and 1 year

Study Arms (2)

1MoreStep Intervention

EXPERIMENTAL

The intervention arm is 8 sessions (7 group and one individual) that meet weekly with a community health educator who is a Black woman and has experience implementing prior behavioral interventions with people who have experienced trauma and/or are LWH.

Behavioral: 1MoreStep

Equal Attention Control

ACTIVE COMPARATOR

The Equal Attention Control consists of 8 sessions (7 group and one individual) that meet weekly for 60-90 minutes. The control sessions provide equal attention and psychotherapeutic experience of a support group where participants can address issues important in their lives.

Behavioral: 1MoreStepControl

Interventions

1MoreStepBEHAVIORAL

Cognitive behavioral intervention to reduce HIV and IPV stigma.

1MoreStep Intervention

This is an equal attention control group.

Equal Attention Control

Eligibility Criteria

Age18 Years+
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsIdentifies as "cisgender": a cisgender woman is a person who was assigned female at birth and presents as a woman
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Cis-gender female
  • Black or African American
  • ≥ Age 18
  • Living with HIV
  • ≤ 1 HIV care visit in previous 12 months OR virally unsuppressed (\>50 copies/mL) OR at high risk for poor HIV care adherence (PHQ ≥ 3, Generalized Anxiety Disorder (GAD) ≥ 3, active substance use)
  • IPV within the previous 2 years
  • Ability to attend in-person for up to 8 sessions
  • Do not report immediate severe danger from their partner
  • English fluency

You may not qualify if:

  • Not a Cis-gender female
  • Not Black or African American
  • ≤ Age17 or younger
  • Not living with HIV
  • ≥ 2 HIV care visits in previous 12 months
  • No IPV within the previous 2 years
  • Inability to attend in-person for up to 8 sessions
  • Reports immediate severe danger from their partner
  • Not fluent in English

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Johns Hopkins School of Nursing

Baltimore, Maryland, 21205, United States

RECRUITING

Related Publications (2)

  • Turan B, Hatcher AM, Weiser SD, Johnson MO, Rice WS, Turan JM. Framing Mechanisms Linking HIV-Related Stigma, Adherence to Treatment, and Health Outcomes. Am J Public Health. 2017 Jun;107(6):863-869. doi: 10.2105/AJPH.2017.303744. Epub 2017 Apr 20.

    PMID: 28426316BACKGROUND
  • Sikkema KJ, Ranby KW, Meade CS, Hansen NB, Wilson PA, Kochman A. Reductions in traumatic stress following a coping intervention were mediated by decreases in avoidant coping for people living with HIV/AIDS and childhood sexual abuse. J Consult Clin Psychol. 2013 Apr;81(2):274-83. doi: 10.1037/a0030144. Epub 2012 Oct 1.

    PMID: 23025248BACKGROUND

MeSH Terms

Conditions

Social StigmaPatient ParticipationMedication Adherence

Condition Hierarchy (Ancestors)

Social BehaviorBehaviorPatient Acceptance of Health CareTreatment Adherence and ComplianceHealth BehaviorPatient Compliance

Study Officials

  • Kamila Alexander

    Johns Hopkins University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Kamila Alexander

CONTACT

Karin Tobin

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants are assigned to one of the two groups for the duration of the study.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 31, 2022

First Posted

November 8, 2022

Study Start

June 26, 2023

Primary Completion (Estimated)

September 1, 2026

Study Completion (Estimated)

December 1, 2026

Last Updated

April 29, 2026

Record last verified: 2026-04

Locations